Protalix BioTherapeutics, Inc. (PLX) has a market capitalization of $190.15M and trades at $2.36. The 52-week range is 1.32-3.19.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -28.1, Earnings Per Share (EPS) of $-0.08, annual revenue of $52.74M.
The stock has a beta of -0.09, operates in the Healthcare sector.
